Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin

Zulma X. Yunt, Michael P. Mohning, Lea Barthel, Mark T. Kearns, Rubin M. Tuder, Dallas M. Hyde, Peter M. Henson, William J. Janssen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose/Aim: Angiogenesis is a central component of normal wound healing but it has not been fully characterized in lung repair following acute inflammatory injury. The current literature lacks vital information pertaining to the extent, timing, and location of this process. This information is necessary for examining mechanisms that drive normal lung repair in resolving acute inflammatory injury. The goal of our study was to formally characterize lung angiogenesis over a time course of bleomycin-induced lung injury. Materials and Methods: Female C57BL/6 mice age 8-12 weeks were treated with a single dose of intratracheal bleomycin. Total lung endothelial cells were quantified with flow cytometry 0, 7, 14, 21, and 28 days following bleomycin administration, and endothelial cell replication was assessed using bromodeoxyuridine (BrdU) incorporation. Results: Endothelial cell replication was maximal 14 days after bleomycin administration, while total lung endothelial cells peaked at day 21. Tissue analysis with stereology was performed to measure total lung vascular surface area in bleomycin at day 21 relative to controls and demonstrated a trend toward increased vasculature in the bleomycin group. Conclusions: Angiogenesis begins shortly after injury in the bleomycin model and leads to an expansion in the lung endothelial cell population that peaks at day 21. This study offers the first longitudinal examination of angiogenesis following acute inflammatory lung injury induced by bleomycin. Information provided in this study will be vital for further investigating mechanisms of angiogenesis in both normal and abnormal lung repair.

Original languageEnglish (US)
Pages (from-to)415-425
Number of pages11
JournalExperimental Lung Research
Volume40
Issue number8
DOIs
StatePublished - Oct 1 2014

Fingerprint

Endothelial cells
Bleomycin
Endothelium
Lung
Kinetics
Wounds and Injuries
Endothelial Cells
Repair
Flow cytometry
Bromodeoxyuridine
Acute Lung Injury
Tissue
Lung Injury
Inbred C57BL Mouse
Wound Healing
Blood Vessels
Flow Cytometry
indium-bleomycin
Population

Keywords

  • Angiogenesis
  • Bleomycin
  • Lung injury
  • Lung repair
  • Pulmonary endothelium
  • Stereology

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Yunt, Z. X., Mohning, M. P., Barthel, L., Kearns, M. T., Tuder, R. M., Hyde, D. M., ... Janssen, W. J. (2014). Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin. Experimental Lung Research, 40(8), 415-425. https://doi.org/10.3109/01902148.2014.938202

Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin. / Yunt, Zulma X.; Mohning, Michael P.; Barthel, Lea; Kearns, Mark T.; Tuder, Rubin M.; Hyde, Dallas M.; Henson, Peter M.; Janssen, William J.

In: Experimental Lung Research, Vol. 40, No. 8, 01.10.2014, p. 415-425.

Research output: Contribution to journalArticle

Yunt, ZX, Mohning, MP, Barthel, L, Kearns, MT, Tuder, RM, Hyde, DM, Henson, PM & Janssen, WJ 2014, 'Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin', Experimental Lung Research, vol. 40, no. 8, pp. 415-425. https://doi.org/10.3109/01902148.2014.938202
Yunt, Zulma X. ; Mohning, Michael P. ; Barthel, Lea ; Kearns, Mark T. ; Tuder, Rubin M. ; Hyde, Dallas M. ; Henson, Peter M. ; Janssen, William J. / Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin. In: Experimental Lung Research. 2014 ; Vol. 40, No. 8. pp. 415-425.
@article{9afd1d554efb43d281cdfeb05e60965d,
title = "Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin",
abstract = "Purpose/Aim: Angiogenesis is a central component of normal wound healing but it has not been fully characterized in lung repair following acute inflammatory injury. The current literature lacks vital information pertaining to the extent, timing, and location of this process. This information is necessary for examining mechanisms that drive normal lung repair in resolving acute inflammatory injury. The goal of our study was to formally characterize lung angiogenesis over a time course of bleomycin-induced lung injury. Materials and Methods: Female C57BL/6 mice age 8-12 weeks were treated with a single dose of intratracheal bleomycin. Total lung endothelial cells were quantified with flow cytometry 0, 7, 14, 21, and 28 days following bleomycin administration, and endothelial cell replication was assessed using bromodeoxyuridine (BrdU) incorporation. Results: Endothelial cell replication was maximal 14 days after bleomycin administration, while total lung endothelial cells peaked at day 21. Tissue analysis with stereology was performed to measure total lung vascular surface area in bleomycin at day 21 relative to controls and demonstrated a trend toward increased vasculature in the bleomycin group. Conclusions: Angiogenesis begins shortly after injury in the bleomycin model and leads to an expansion in the lung endothelial cell population that peaks at day 21. This study offers the first longitudinal examination of angiogenesis following acute inflammatory lung injury induced by bleomycin. Information provided in this study will be vital for further investigating mechanisms of angiogenesis in both normal and abnormal lung repair.",
keywords = "Angiogenesis, Bleomycin, Lung injury, Lung repair, Pulmonary endothelium, Stereology",
author = "Yunt, {Zulma X.} and Mohning, {Michael P.} and Lea Barthel and Kearns, {Mark T.} and Tuder, {Rubin M.} and Hyde, {Dallas M.} and Henson, {Peter M.} and Janssen, {William J.}",
year = "2014",
month = "10",
day = "1",
doi = "10.3109/01902148.2014.938202",
language = "English (US)",
volume = "40",
pages = "415--425",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin

AU - Yunt, Zulma X.

AU - Mohning, Michael P.

AU - Barthel, Lea

AU - Kearns, Mark T.

AU - Tuder, Rubin M.

AU - Hyde, Dallas M.

AU - Henson, Peter M.

AU - Janssen, William J.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Purpose/Aim: Angiogenesis is a central component of normal wound healing but it has not been fully characterized in lung repair following acute inflammatory injury. The current literature lacks vital information pertaining to the extent, timing, and location of this process. This information is necessary for examining mechanisms that drive normal lung repair in resolving acute inflammatory injury. The goal of our study was to formally characterize lung angiogenesis over a time course of bleomycin-induced lung injury. Materials and Methods: Female C57BL/6 mice age 8-12 weeks were treated with a single dose of intratracheal bleomycin. Total lung endothelial cells were quantified with flow cytometry 0, 7, 14, 21, and 28 days following bleomycin administration, and endothelial cell replication was assessed using bromodeoxyuridine (BrdU) incorporation. Results: Endothelial cell replication was maximal 14 days after bleomycin administration, while total lung endothelial cells peaked at day 21. Tissue analysis with stereology was performed to measure total lung vascular surface area in bleomycin at day 21 relative to controls and demonstrated a trend toward increased vasculature in the bleomycin group. Conclusions: Angiogenesis begins shortly after injury in the bleomycin model and leads to an expansion in the lung endothelial cell population that peaks at day 21. This study offers the first longitudinal examination of angiogenesis following acute inflammatory lung injury induced by bleomycin. Information provided in this study will be vital for further investigating mechanisms of angiogenesis in both normal and abnormal lung repair.

AB - Purpose/Aim: Angiogenesis is a central component of normal wound healing but it has not been fully characterized in lung repair following acute inflammatory injury. The current literature lacks vital information pertaining to the extent, timing, and location of this process. This information is necessary for examining mechanisms that drive normal lung repair in resolving acute inflammatory injury. The goal of our study was to formally characterize lung angiogenesis over a time course of bleomycin-induced lung injury. Materials and Methods: Female C57BL/6 mice age 8-12 weeks were treated with a single dose of intratracheal bleomycin. Total lung endothelial cells were quantified with flow cytometry 0, 7, 14, 21, and 28 days following bleomycin administration, and endothelial cell replication was assessed using bromodeoxyuridine (BrdU) incorporation. Results: Endothelial cell replication was maximal 14 days after bleomycin administration, while total lung endothelial cells peaked at day 21. Tissue analysis with stereology was performed to measure total lung vascular surface area in bleomycin at day 21 relative to controls and demonstrated a trend toward increased vasculature in the bleomycin group. Conclusions: Angiogenesis begins shortly after injury in the bleomycin model and leads to an expansion in the lung endothelial cell population that peaks at day 21. This study offers the first longitudinal examination of angiogenesis following acute inflammatory lung injury induced by bleomycin. Information provided in this study will be vital for further investigating mechanisms of angiogenesis in both normal and abnormal lung repair.

KW - Angiogenesis

KW - Bleomycin

KW - Lung injury

KW - Lung repair

KW - Pulmonary endothelium

KW - Stereology

UR - http://www.scopus.com/inward/record.url?scp=84907271033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907271033&partnerID=8YFLogxK

U2 - 10.3109/01902148.2014.938202

DO - 10.3109/01902148.2014.938202

M3 - Article

VL - 40

SP - 415

EP - 425

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 8

ER -